Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/12
Title: Frequency of Expression of D240 in Dermatofibroma – A diagnostic study
Authors: Maimoona Aslam
A.S. Chughtai
Azra Bashir
Faria Waqar Khan
Alina Naeem
Anam Khan
Keywords: Dermatofibroma
Haematoxylin
Immunohistochemical
Positivity of D2-40
Issue Date: Jan-2022
Publisher: Pakistan Journal of Medical & Health Sciences (PJMHS)
Series/Report no.: Vol. 16;No.01
Abstract: Aim: To establish the diagnostic utility of D2-40 IHC stain in dermatofibroma, by determining its positivity of expression. Study design: It was a Cross-sectional study Setting: The study was conducted in Department of Histopathology, Chughtai Institute of Pathology Duration of study: Six months (1st August 2018 to 31st January 2019) Methods: A total 70 samples were included. The clinical parameters like age and gender were recorded. The histological preparation was performed by classic method for inclusion in paraffin followed by haematoxylin-eosin staining. The immunohistochemical analysis was performed on serial sections using immune-enzymatic soluble complex method. The antibody used was D2-40 polyclonal antibody from DAKO. Diffuse crisp cytoplasmic D2-40 staining was considered positive. Results: The mean age was 32.76±10.65 years and male to female ratio was 1:1.4. There were 70% cases have D2-40 positivity for dermatofibroma and 30% have no D2-40 positivity for dermatofibroma and mean duration of disease was 9.05±6.33 months. There were significant difference (P<0.05) between age and duration of disease with respect to D2-40 positivity for dermatofibroma; Conclusion: D2-40 immunoreactivity is sensitive and is useful in the differential diagnosis of dermatofibroma.
URI: http://localhost:8080/xmlui/handle/123456789/12
ISSN: 1996-7195 (Print)
2957-899X (Online)
Appears in Collections:Histopathology

Files in This Item:
File Description SizeFormat 
37.pdf354.81 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.